Defective Drugs and Supplements

When pharmaceutical companies release dangerous and defective drugs into the marketplace, patients who are injured as a result may be able to take legal action. Typically, these lawsuits allege that a pharmaceutical company made a drug that was somehow defective – either in design, manufacturing or marketing. A drug suffers from a marketing defect if the company failed to properly warn patients or doctors about a certain side effect.

It’s important to note that most lawsuits involving pharmaceutical drugs aren’t class action lawsuits, but rather individual lawsuits filed by one person with the help of his or her attorney. (You can find out why drug lawsuits aren’t suited for class action litigation by reading this article.)

If you’ve been injured by any of the drugs listed below, get in touch with us today by filling out this form. There’s no cost or obligation to contact us or to talk to an attorney about whether you can file a lawsuit.

ClassAction.org Newsletter

Stay Current

Sign Up For
Our Newsletter

New cases and investigations, settlement deadlines, and news straight to your inbox.

Sign up for our newsletter or follow us on Twitter to stay up to date on lawsuit settlements.

Lawsuits are being filed claiming that the makers of certain Similac and Enfamil infant formula products failed to warn healthcare providers and caregivers that ingesting cow’s milk-based formulas can cause premature babies to develop necrotizing enterocolitis.

Lawsuits are being filed against companies that continue to sell and market unwashed poppy seeds, which can be steeped in water to make tea, despite being well aware that the seeds contain dangerous levels of opium and have been responsible for several deaths around the world.

Women across the country have filed lawsuits against Johnson & Johnson alleging that the company's talcum powders can cause ovarian cancer when used near the genitals.

Tepezza has been linked to potentially permanent hearing loss and other hearing impairments, and lawsuits have been filed claiming the manufacturer did not adequately warn patients about this risk.